The elderly type 2 diabetic patient: Special considerations

Diabetic Medicine

Volumn 15, Issue SUPPL. 4, 1998, Pages

  Morley, John E ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cognitive deterioration; Depression; Diabetes mellitus; Functional impairment; Hypoglycaemia; Hypogonadism; Older people; Pain

Indexed keywords

INSULIN; LEPTIN;

AGED; BLOOD GLUCOSE MONITORING; CAREGIVER; COGNITION; DEPRESSION; DIETARY INTAKE; DISEASE ASSOCIATION; ELDERLY CARE; HUMAN; HYPERGLYCEMIA; HYPOGONADISM; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN THRESHOLD; PHYSICAL ACTIVITY; REVIEW;

AGED; AMYLOID; BLOOD GLUCOSE; CARBAMATES; COGNITION DISORDERS; DEPRESSION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; PIPERIDINES;

EID: 0031736785     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-9136(1998120)15:4+3.3.co;2-5     Document Type: Article

References (68)

1. Harris MI, Madden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yrs. Diabetes 1987; 36(4): 523-534.
2. Knowler WC, Saad MF, Pettitt DJ, Nelson RC, Bennett PH. Determinants of diabetes mellitus in the Pima Indians. Diabetes Care 1993; 16(1): 216-227.
3. Croxson SC, Burden AC, Bodington M, Botha JL. The prevalence of diabetes in elderly people. Diabet Med 1991; 8(1): 28-31.
4. Tuomilehto J, Nissinen A, Kivela S-L et al. Prevalence of diabetes mellitus in elderly men aged 65 to 84 years in eastern and western Finland. Diabetologia 1986; 29(a): 611-615.
5. Mykkanen L, Laakso M, Uusitupa M, Pyorala K. Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes. Diabetes Care 1990; 13(11):1099-1105.
6. Perry HM III, Morley JE, Horowitz M, Kaiser FE, Miller DK, Witter TG. Body composition and age in African American and Caucasian women: Relationship to plasma leptin levels. Metabolism 1997; 46(12): 1399-1405.
7. Silver AJ, Guillen CP, Kahl MJ, Morley JE. Effect of aging on body fat. J Am Geriatr Soc 1993; 41(3): 211-213.
8. Mayfield JA, Deb P, Potter DEB. Diabetes and long-term care (chapter 28). Diabetes in America. NIH Publication No. 95: 1468, 2nd ed, Bethesda, MD. National Institutes of Health, 1995, pp. 571-590.
9. Weinberger M, Cowper PA, Kirkman MS, Vinicor F. Economic impact of diabetes mellitus in the elderly. Clin Geriatr Med 1990; 6: 959-970.
10. Morley JE, Perry HM III. The management of diabetes mellitus in older individuals. Drugs 1991; 41(4): 548-565.
11. Naliboff BD, Rosenthal M. Effects of age on complications in adult onset diabetes. J Am Geriatr Soc 1989; 37(9): 838-842.
12. Wachtel TJ. The diabetic hyperosmolar state. Clin Geriatr Med 1990; 6(4): 797-806.
13. Sinclair AJ, Robert IE, Croxson SC. Mortality in older people with diabetes mellitus. Diabet Med 1997; 14(8): 639-647.
14. Mooradian AD, Osterweil D, Petrasek D, Morley JE. Diabetes mellitus in elderly nursing home patients: A survey of clinical characteristics and management. J Am Geriatr Soc 1988; 36(5): 391-396.
15. Miller DK, Perry HM III, Kaiser FE, Morley JE. Diabetes mellitus and functional status in older inner city African Americans. Gerontologist 1996; 36: 130.
16. Bourdel-Marchasson I, Dubroca B, Manciet G, Decamps A, Emeriau JP, Dartigues JF. Prevalence of diabetes and effect on quality of life in older French living in the community: The PAQUID Epidemiological Survey. J Am Geriatr Soc 1997; 45(3): 295-301.
17. Morley JE. Diabetes mellitus: New approaches to management. Clin Geriatr 1996; 4: 75-81.
18. Klein BE, Klein R, Moses SE. Self-rated health and diabetes of long duration. The Wisconsin Epidemiological Study of Diabetic Retinopathy. Diabetes Care 1998; 21(2): 236-240.
19. Bourdel-Marchasson I, Dubroca B, Manciet G, Decamps A, Emeriau JP, Dartigues JF. Prevalence of diabetes and effect on the quality of life in older French living in the community: the PAQUID Survey. J Am Ger Soc 1997; 45(3): 295-301.
20. Taylor R, Foster B, Kyne-Grzebalski D, Vanderpump M. Insulin regimens for the non-insulin-dependent: impact on diurnal metabolic state and quality of life. Diabet Med 1994; 11(6): 551-557.
21. Lehto S, Ronnemaa T, Pyorala K, Laakso M. Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care 1996; 19(6): 607-612.
22. Laakso M. Glycemic control and the risk of coronary heart disease in patients with non-insulin-dependent diabetes mellitus. The Finnish studies. An Intern Med 1996; 124(1 Pt 2): 127-130.
23. Morisaki N, Watanabe S, Kobayashi J, Kanzaki T, Takahashi K, Yokote K, Tezuka M, Inadera H, Saito Y et al. Diabetic control and progression of retinopathy in elderly patients: five-year follow-up study. J Am Ger Soc 1994; 42(2): 142-145.
24. Mooradian AD, Perryman K, Fitten J, Kavonian GD, Morley JE. Cortical function in elderly non-insulin dependent diabetic patients. Behavioral and electrophysiological studies. Arch Intern Med 1988; 148(11): 2369-2372.
25. Morley JE, Flood JF. Psychosocial aspects of diabetes mellitus in older persons. J Am Geriatr Soc 1990; 38(5): 605-606.
26. Strachan MW, Deary IJ, Ewing FM, Frier BM. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 1997; 20(3), 438-445.
27. Flood JF, Mooradian AD, Morley JE. Characteristics of learning and memory in streptozocin-induced diabetic mice. Diabetes 1990; 39(11): 1391-1398.
28. Gradman TJ, Laws A, Thompson LW, Reaven GM. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J Am Geriatr Soc 1993; 41(12): 1305-1312.
29. Meneilly GS, Cheung E, Tessier D, Yakura C, Tuokko H. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. J Gerontol 1993; 48(4): M117-M121.
30. Rost K, Roter D, Quill T, Bertakis K. Capacity to remember prescription drug changes: Deficits associated with diabetes. Collaborative Study Group of the Task Force on the Medical Interview. Diabetes Res Clin Pract 1990; 10(2): 183-187.
31. Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care 1997; 20(4): 585-590.
32. Rosenthal MJ, Fajardo M, Gilmore S, Morley JE, Naliboff BD. Hospitalization and mortality of diabetes in older adults. A three-year prospective study. Diabetes Care 1998; 21(2): 231-235.
33. Brandeis GH, Ooi WL, Hossian M, Morris JN, Lipsitz LA. A longitudinal study of risk factors associated with the formation of pressure ulcers in nursing homes. J Am Geriatr Soc 1994; 42(4): 388-393.
34. Kinlaw WB, Levine AS, Morley JE, Silvis SE, McClain CJ. Abnormal zinc metabolism in Type II diabetes mellitus. Am J Med 1983; 75(2): 273-277.
35. Niewoehner CB, Allen JI, Boosalis M, Levine AS, Morley JE. The role of zinc supplementation in Type II diabetes mellitus. Am J Med 1986; 81(1): 63-68.
36. Lipsky BA, Pecoraro RE, Ahroni JH. Foot ulceration and infections in elderly diabetics. Clin Geriatr Med 1990; 6(4): 747-769.
37. Damsgaard EM. Why do elderly diabetics burden the health care system more than non-diabetics. Danish Med Bull 1989; 36(1): 89-92.
38. Morley GK, Mooradian AD, Levine AS, Morley JE. Mechanism of pain in diabetic peripheral neuropathy. Effect of glucose on pain perception in humans. Am J Med 1984; 77(1): 79-82.
39. Raz I, Hasdai D, Seltzer Z, Melmed RN. Effect of hyperglycemia on pain perception and on efficacy of morphine analgesia in rats. Diabetes 1988; 37(9): 1253-1259.
40. Erase DA, Han YH, Dewey WL. Effects of glucose and diabetes on binding of naloxone and dihydromorphine to opiate receptors in mouse brain. Diabetes 1987; 36(10): 1173-1177.
41. Province MA, Hadley EC, Hornbrook MC, Lipsitz LA, Miller JP, Mulrow CD, Ory MG, Sattin RW, Tinetti ME, Wolf SL. The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT trials. Frailty and Injuries: Cooperative Studies of Intervention Techniques. JAMA 1995; 273(17): 1341-1347.
42. Pablos-Mendez A, Blustein J, Knirsch CA. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Pub Health 1997; 87(4): 574-579.
43. Morley JE. Nutrition and the older female: a review. J Am Coll Nutr 1993; 12(4): 337-343.
44. Silver AJ, Morley JE. Role of the opioid system in the hypodipsia associated with aging. J Am Geriatr Soc 1992; 40(6): 556-560.
45. Morley JE. Sex hormones and diabetes mellitus. Diabetes Rev 1998; 6: 6-15.
46. Morley JE, Charlton E, Patrick P, et al. Validation of the androgen deficiency in aging males (ADAM) screening questionnaire. Endo Soc 1998; in press.
47. Coulston AM, Mandelbaum D, Reaven GM. Dietary management of nursing home residents with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1990; 51(1): 67-71.
48. Buckler DA, Kelber ST, Goodwin JS. The use of dietary restrictions in malnourished nursing home patients. J Am Geriatr Soc 1994; 42(10): 1100-1102.
49. Morley JE. Diabetes mellitus: New approaches to management. Clin Geriatr 1996; 4: 75-81.
50. Hirokawa CA, Gray DR. Chlorpropramide-induced hyponatremia in the veteran population. Ann Pharmacother 1992; 26(10): 1243-1244.
51. Morley JE, Mooradian AD, Rosenthal MJ, Kaiser FE. Diabetes mellitus in elderly patients. Is it different? Am J Med 1987; 83(3): 533-544.
52. Lee A, Morley JE. Metformin, anorexia and weight loss. Obesity Research 1998; 6: 47-53.
53. Morley JE. Anorexia of aging: physiologic and pathologic (review). Am J Clin Nutr 1997; 66(4): 760-773.
54. McFarland KF. Type 2 diabetes -stepped care approach to patient management. Geriatrics 1997; 52(10): 22.
55. Bressler R, Johnson DG. Oral antidiabetic drug use in the elderly. Drugs and Aging 1996; 9(6): 418-437.
56. Kumar S, Boulton AJM, Beck-Nielsen HJ, Berthezene F, Muggeo M, Persson B, Spinas GA, Donoghue S, Lettis S, Stewart-Long P. Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Diabetologia 1996; 39(6): 701-709.
57. Schwartz S, Raskin P, Fonseca V, Graveline JF. Effect of troglitazone in insulin-treated patients with Type 2 diabetes mellitus. NEJM 1998; 338(13): 861-866.
58. Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, Shulman GI. Efficacy and metabolic effects of metformin and troglitazone in Type 2 diabetes mellitus. NEJM 1998; 338(13): 867-872.
59. Anonymous. Therapeutic Monograph - Type 2 Diabetes. United States Pharmacopeia Dispensing Information Update (July) 1998: 982-1028.
60. Watkins PB, Whitcomb RW. Hepatic dysfunction associated with troglitazone. NEJM 1998; 338(13): 916-917.
61. Dejgaard A, Madsbad S, Kilhovd B, Lager I, Mustajoki P. Repaglinide compared to glipizide in the treatment of Type 2 diabetic patients. Diabetologia 1998; 41(Suppl 1): A236.
62. Marbury TC, Hatorp V. Pharmacokinetics of repaglinide after single and multiple doses in patients with renal impairment compared with normal healthy volunteers. Diabetes 1998; 47 (Suppl 1): A357.
63. Marbury TC, Hatorp V, Damsbo P, Müller PG. Repaglinide can be given in a flexible preprandial dosing regimen in patients with Type 2 diabetes. Diabetologia 1998; 41 (Suppl 1): A236.
64. Tronier B, Marbury TC, Damsbo P. A new oral hypoglycaemic agent, repaglinide, minimises the risk of hypoglycaemia in well controlled NIDDM patients. Diabetologia 1995; 38 (Suppl 1): A195.
65. Gilden JL, Hendryx MX, Clar S, Casia C, Singh SP. Diabetes support groups improve health care of older diabetic patients. J Am Geriatr Soc 1992; 40(2): 147-150.
66. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347 (9004): 781-786.
67. Morisaki N, Watanabe S, Kobayashi J, Kanzaki T, Takahashi K, Yokote K, Tezuka M, Tashiro J, Inadera H, Saito Y, et al. Diabetic control and progression of retinopathy in elderly patients: Five-year follow-up study. J Am Geriatr Soc 1994; 42(2): 142-145.
68. Laakso M. Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. The Finnish studies. Ann Intern Med 1996; 124(1 pt 2): 127-130.